Hostname: page-component-7dd5485656-k8lnt Total loading time: 0 Render date: 2025-10-30T12:24:48.164Z Has data issue: false hasContentIssue false
  • English
  • Français

Lithium Augmentation Therapy in Tricyclic-Resistant Depression

A Controlled Trial Using Lithium in Low and Normal Doses

Published online by Cambridge University Press:  02 January 2018

George Stein  and
Morris Bernadt
George Stein
Affiliation:
Farnborough Hospital, Farnborough Common, Farnborough, Kent BR6 8ND and King's College Hospital
Morris Bernadt
Affiliation:
Department of Psychological Medicine, King's College Hospital, Denmark Hill, London SE5 9RS
Get access Rights & Permissions [Opens in a new window]

Abstract

Thirty-four patients with tricyclic-resistant depressive illness took part in a nine-week, doubleblind, placebo-controlled trial of lithium augmentation. In addition to the maximum tolerated doses of their tricyclic antidepressant, the experimental group (n = 16) received 250 mg lithium daily for three weeks, followed by 750 mg lithium daily for six weeks, while the controls (n = 18) received placebo for three weeks followed by three weeks each of 250 mg lithium daily and 750 mg lithium daily. There was no significant difference between placebo and 250 mg lithium for weeks 0-3 of the trial. However, there was a significantly greater improvement on the MADRS for weeks 3-6 for those subjects on 750 mg lithium than for those on 250 mg lithium. In addition, using a 50% fall in the HRSD as a criterion of drug responsiveness, 22% responded to placebo, 18% to 250 mg lithium, and 44% to 750mg lithium. Thus, lithium in normal, but not in low, dose has a significant antidepressant effect in TCA-resistant depression. Further controlled studies using lithium in normal dose in trials which have a greater duration of placebo exposure are required to confirm the lithium augmentation effect.

Information

Type
Research Article
Information
The British Journal of Psychiatry , Volume 162 , Issue 5 , May 1993 , pp. 634 - 640
Copyright
Copyright © Royal College of Psychiatrists, 1993 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Altman, D. G. (1991) Randomisation. British Medical Journal, 302, 1481–1482.CrossRefGoogle ScholarPubMed
Austin, M. P. V., Souza, F. G. M. & Goodwin, G. M. (1991) Lithium augmentation in antidepressant resistant patients. A quantitative analysis. British Journal of Psychiatry, 159, 510–514.Google Scholar
Austin, S. L., Arana, G. W. & Melvin, A. J. (1990) Toxicity resulting from lithium augmentation of anti-depressant treatment in elderly patients. Journal of Clinical Psychiatry, 51, 344–345.Google Scholar
Broderick, P. & Lynch, V. (1982) Behavioural and biochemical changes induced by lithium and L-tryptophan in muricdal rats. Neuropharmacology, 21, 671–679.Google Scholar
Charney, D. S. & Nelson, J. C. (1981) Delusional and non-delusional unipolar depression: further evidence for distinct subtypes. American Journal of Psychiatry, 138, 328–333.Google Scholar
De Montigny, C., Grunberg, M., Mayer, A., et al (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. British Journal of Psychiatry, 138, 252–256.Google Scholar
De Montigny, C., Grunberg, M., Mayer, A., Cournoyer, G., Morissette, R., et al (1983) Lithium carbonate addition to tricyclic antidepressant-resistant unipolar depression. Archives of General Psychiatry, 40, 1327–1334.CrossRefGoogle ScholarPubMed
De Montigny, C., Grunberg, M., Mayer, A., Cournoyer, G., Morissette, R., Elie, R. & Caille, G. (1985) Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study. American Journal of Psychiatry, 142, 220–223.Google Scholar
Dinan, T. G. & Barry, S. (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic non-responders. Acta Psychiatrica Scandinavica, 80, 97–100.Google Scholar
Ghose, K. (1977) Lithium salts - therapeutic and unwanted effects. British Journal of Hospital Medicine, 18, 578–583.Google ScholarPubMed
Grahame-Smith, D. G. & Green, A. R. (1974) The role of brain 5-hydroxytriptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. British Journal of Pharmacology, 52, 19–26.Google Scholar
Goodwin, F. K., Prange, A. J., Post, R. M., et al (1982) Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non-responders. American Journal of Psychiatry, 139, 34–38.Google Scholar
Hale, A. S., Procter, A. W. & Bridges, P. K. (1987) Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. British Journal of Psychiatry, 151, 213–217.Google Scholar
Hall, R. C. W., Gardner, E. R., Popkin, M. R., et al (1981) Unrecognised physical illness prompting psychiatric admission: a prospective study. American Journal of Psychiatry, 138, 629–635.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.Google Scholar
Henninger, G. R., Charney, D. S. & Sternberg, D. E. (1983) Lithium carbonate augmentation of antidepressant treatment. Archives of General Psychiatry, 40, 1335–1342.Google Scholar
Kantor, D., McNevin, S., Leichner, P., et al (1986) The benefit of lithium carbonate adjunct in refractory depression - fact or fiction? Canadian Journal of Psychiatry, 31, 416–418.CrossRefGoogle ScholarPubMed
Katona, C. L. E. (1988) Lithium augmentation in refractory depression. Psychiatric Developments, 2, 153–171.Google Scholar
Khan, M. C., Wickham, E. A. & Read, J. V. (1987) Lithium versus placebo in acute depression: a clinical trial. International Clinics of Psychopharmacology, 2, 47–54.Google Scholar
Klein, D. E., Gittleman, R., Quitkin, F. M., et al (1980) Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children (2nd edn). Baltimore: Williams and Wilkins.Google Scholar
Koryani, E. K. (1979) Morbidity and rate of undiagnosed physical illness in a psychiatric clinic population. Archives of General Psychiatry, 36, 414–419.CrossRefGoogle Scholar
Kushnir, S. L. (1986) Lithium antidepressant combinations in the treatment of depressed, physically ill geriatric patients. American Journal of Psychiatry, 143, 378–379.Google Scholar
Lee, A. S. & Murray, R. M. (1988) The long-term outcome of Maudsley depressives. British Journal of Psychiatry, 153, 741–751.Google Scholar
Lingjaerde, O., Edlund, A. H., Gormsen, C. A., et al (1974) The effect of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. Acta Psychiatrica Scandinavica, 50, 233–242.Google Scholar
Louie, A. K. & Meltzer, H. Y. (1984) Lithium potentiation of antidepressant treatment. Journal of Clinical Psychopharmacology, 4, 316–321.CrossRefGoogle ScholarPubMed
Maguire, G. P. & Granville-Grossman, K. L. (1968) Physical illness in psychiatric patients. British Journal of Psychiatry, 115, 1365–1369.CrossRefGoogle Scholar
Montgomery, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 383–389.Google Scholar
Pai, M., White, A. C. & Deane, A. G. (1986) Lithium augmentation in the treatment of delusional depression. British Journal of Psychiatry, 134, 383–389.Google Scholar
Pare, C. M. B. (1963) Potentiation of monoamine oxidase inhibitors by tryptophan. Lancet, i, 527–528.CrossRefGoogle Scholar
Price, L. H., Conwell, Y. & Nelson, J. C. (1983) Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. American Journal of Psychiatry, 140, 318–322.Google Scholar
Price, L. H., Conwell, Y. & Nelson, J. C., Charney, D. S. & Henninger, G. R. (1986) Variability of response to lithium augmentation in refractory depression. American Journal of Psychiatry, 143, 1387–1392.Google Scholar
Quitkin, F. M., Rabkin, J. G., Ross, D., et al (1984) Duration of antidepressant drug treatment. Archives of General Psychiatry, 41, 238–245.Google Scholar
Schopf, J. (1989) Treatment of depressions resistant to tricyclic antidepressants: review of the literature. Pharmacopsychiatry, 22, 174–182.Google Scholar
Schopf, J., Baumann, P., Lemarchand, T., et al (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Pharmacopsychiatry, 22, 183–187.Google Scholar
Schou, M. (1990) Lithium and treatment-resistant depressions: a review. Lithium, i, 3–8.Google Scholar
Spitzer, R. L., Endicott, J. & Robins, E. (1975) Research Diagnostic Criteria (RDC). New York: Biometrics Research, New York State Psychiatry Institute.Google Scholar
Worral, E. P. (1986) Lithium augmentation of tricyclics. British Journal of Psychiatry, 149, 520–521.CrossRefGoogle Scholar
Worral, E. P., Moody, J. P., Peet, M., et al (1979) Controlled studies of the acute antidepressant effects of lithium. British Journal of Psychiatry, 35, 255–262.Google Scholar
Zusky, P. M., Biederman, J., Rosenbaum, J. F., et al (1986) Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo controlled study. Journal of Clinical Psychopharmacology, 8, 120–124.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.